About 90,800 results
Open links in new tab
  1. Tardive Dyskinesia Videos & Stories - AUSTEDO XR

    Watch patient story videos discussing their Tardive Dyskinesia (TD) and experiences with AUSTEDO XR® extended release tablets. See safety info and boxed warning.

  2. Patients Taking AUSTEDO XR® (deutetrabenazine) extended …

    Sep 20, 2025 · These survey results highlight the positive patient experience with AUSTEDO XR, demonstrating that, as a result of reduced motor symptoms, patients living with TD …

  3. Teva Pharmaceutical Industries Ltd. - Patients Taking AUSTEDO XR ...

    Sep 20, 2025 · Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) …

  4. AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...

    4 days ago · “These data articulate patient experience and further validate clinical research showing how AUSTEDO or AUSTEDO XR can help people living with tardive dyskinesia …

  5. Teva Pharmaceutical Industries Shares Positive Patient Survey …

    High patient satisfaction was reported, with over 89% expressing interest in continuing treatment. 96% of patients found AUSTEDO XR easy to take, highlighting its favorable patient …

  6. Study Explores Tardive Dyskinesia Outcomes With …

    Nov 12, 2024 · Teva also presented findings on real-world patient experience with Austedo XR from a noninterventional, prospective, cross-sectional survey. The survey included adults with …

  7. Patients Using AUSTEDO XR® (deutetrabenazine) Extended …

    Sep 21, 2025 · Patient Satisfaction with AUSTEDO XR: A survey of 209 patients with tardive dyskinesia (TD) revealed that over 94% experienced movement improvement after treatment …

  8. Patients Taking AUSTEDO XR® (deutetrabenazine) extended …

    Sep 21, 2025 · These survey results highlight the positive patient experience with AUSTEDO XR, demonstrating that, as a result of reduced motor symptoms, patients living with TD …

  9. Real-World Data Show AUSTEDO XR Delivers High Patient

    Patient satisfaction remained consistently high across both groups, with 91% of patients with prior valbenazine use and 89% of treatment-naïve patients reporting overall satisfaction with …

  10. Teva Presents New Tardive Dyskinesia Data at Psych Congress …

    Nov 1, 2024 · Teva also announced interim data from a patient-reported survey describing early, real-world experience with AUSTEDO XR. These findings are being presented at the Psych …